9 unchanged sentences
District Court for the Northern District of Ohio and includes approximately 230 cases with claims against the Company as of March 6, 2026.
−Removed: In addition, there are more than 25 other opioid-related cases against the Company and its subsidiaries pending in U.S.
+Added: In addition, the following 13 other opioid-related cases against the Company and its subsidiaries were pending in U.S.
state and federal courts and Canadian courts as of March 6, 2026:
−Removed: The non-MDL case citations are listed on Exhibit 99.1 to this Annual Report on Form 10-K.
+Added: Baby Doe 1, et al.
+Added: Allergan Finances, LLC, et al., U.S.
+Added: Tenn., 4/29/25;
+Added: Marshall Cty.
+Added: of Educ., et al.
+Added: Cephalon, Inc., et al., U.S.
+Added: Va., 10/28/24;
+Added: CVS Pharm., Inc., et al., Nev.
+Added: Ct., Nye Cty., 2/26/24;
+Added: CVS Pharm., Inc., et al., Ky.
+Added: Ct., Perry Cty., 12/11/23;
+Added: City of Grande Prairie, et al.
+Added: Apotex Inc., et al., Alta.
+Added: King's Bench Ct., Calgary Jud.
+Added: Ctr., 4/27/23;
+Added: Lac La Ronge Indian Band, et al.
+Added: Apotex Inc., et al., Sask.
+Added: King's Bench Ct., Prince Albert Jud.
+Added: Ctr., 3/17/23;
+Added: Commonwealth of Pennsylvania ex rel.
+Added: Allegheny Cty.
+Added: Att'y Stephen A.
+Added: CVS Ind., LLC, et al., Pa.
+Added: Pl., Delaware Cty., 8/8/22;
+Added: Baby Doe, et al., ex rel.
+Added: Their Guardian Ad Litem v.
+Added: Endo Health Sols., Inc., et al., U.S.
+Added: Tenn., 8/3/22;
+Added: Paynter ex rel.
+Added: Minor Child(ren) Z.N.B.
+Added: McKesson Corp., et al., W.
+Added: Ct., Kanawha Cty., 3/28/22;
+Added: Blankenship ex rel.
+Added: Minor Child Z.D.B.
+Added: McKesson Corp., et al., W.
+Added: Ct., Kanawha Cty., 1/14/22;
+Added: Amneal Pharm., LLC, et al., Miss.
+Added: Dist., Hinds Cty.
+Added: Ct., 5/15/20;
+Added: d/b/a Parkland Health & Hosp.
+Added: Sys., et al., v.
+Added: Amneal Pharm., LLC, et al., Tex.
+Added: Ct., 152nd Jud.
+Added: Dist., Harris Cty., 11/20/19;
+Added: Ctr., Inc., et al.
+Added: Sackler, et al., Fla.
+Added: Ct., 17th Jud.
+Added: Cir., Broward Cty., 9/16/19.
DOJ Opioid Civil Litigation:
5 unchanged sentences
As of January 31, 2025, all of the accrued liability has been paid.
−Removed: Certain eligible political subdivisions and federally recognized Native American tribes have until July 15, 2025 and February 24, 2026, respectively, to join the settlement.
−Removed: Opioid-Related Derivative Lawsuits:
−Removed: Alvarez et al.
−Removed: , USDC, Dist.
−Removed: of DE, 2/9/21;
−Removed: McMillon et al., USDC, Dist.
−Removed: of DE, 4/16/21;
−Removed: Ontario Provincial Council of Carpenters' Pension Trust Fund et al.
−Removed: Walton et al., DE Court of Chancery, 9/27/21.
−Removed: Opioid-Related Securities Class Actions:
−Removed: , USDC, Dist.
−Removed: of DE, 1/20/21 and Martin v.
−Removed: et al., USDC , Dist.
−Removed: of DE, 3/5/21, consolidated into In re Walmart Inc.
−Removed: Securities Litigation , USDC, Dist.
−Removed: of DE, 5/11/21;
−Removed: In re Walmart Inc.
−Removed: Securities Litigation, USCCA, 3d Cir., 4/29/24.
False Claims Act Litigation:
8 unchanged sentences
and Abusubih & Others v Asda Stores limited (KB-2022-003240).
−Removed: Money Transfer Agent Services Litigation:
−Removed: Federal Trade Commission v.
−Removed: Of Ill, 6/28/22;
−Removed: Federal Trade Commission v.
−Removed: , USCCA, 7th Cir., 10/28/24.
−Removed: Driver Platform Matter:
−Removed: Consumer Financial Protection Bureau v.
−Removed: Walmart Inc., et al.
−Removed: of Minn., 12/23/24.
+Added: Federal Trade Commission and State Attorneys General Driver Platform Litigation:
+Added: Federal Trade Commission, et al.
+Added: Cal., 2/26/26 .
Mexico Antitrust Matter:
6 unchanged sentences
ENVIRONMENTAL MATTERS:
−Removed: Item 103 of SEC Regulation S-K requires disclosure of certain environmental matters when a governmental authority is a party to the proceedings and such proceedings involve potential monetary sanctions that the Company reasonably believes will exceed an applied threshold not to exceed $1 million.
+Added: Item 103 of SEC Regulation S-K requires disclosure of certain environmental matters when a governmental authority is a party to the proceedings and such proceedings involve potential monetary sanctions that the Company reasonably believes will exceed $1 million.
In October 2023, the Company received a Finding of Violation from the U.S.
Environmental Protection Agency (the "EPA") alleging violations of the Clean Air Act in connection with the Company's refrigeration leak detection and repair program at certain of its facilities.
−Removed: The Company is evaluating the findings and cooperating with the EPA in its investigation.
+Added: The Company is cooperating with the EPA in its investigation.
The EPA may seek to impose monetary and non-monetary penalties for the alleged violations of the Clean Air Act.
−Removed: Due to the fact that this process is in an early stage, the Company is unable to predict the final outcome of this matter.
+Added: The Company is unable to predict the final outcome of this matter, but the EPA could seek penalties in excess of $1 million.
Although the Company does not believe this matter will have a material adverse effect on its business, financial position, results of operations, or cash flows, the Company can provide no assurance that its business, financial position, results of operations or cash flows will not be materially adversely affected.
2 unchanged sentences
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.